CTLA4 and cancer: Based on the consideration that ICD induction can sensitize cancer to subsequent ICB treatment31, ICB was performed after the treatment with (R)-crizotinib and CDDP by three injections of CTLA-4 and PD-1 blocking antibodies, starting from 8 days after the administration of the small molecules (Fig. 7a).